J&J's Priligy becomes first approved drug for premature ejaculation
This article was originally published in Scrip
Executive Summary
Janssen-Cilag's (Johnson & Johnson) SSRI Priligy (dapoxetine) has become the first drug to receive approval specifically for the treatment of premature ejaculation.